ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,336.87
-0.87%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IO Biotech Inc (IOBT)

  7. IO Biotech Inc (IOBT) Noticias

IOBT IO Biotech Inc

1.48
-0.05 (-3.27%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
IO Biotech Inc IOBT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.05 -3.27% 1.48 16:30:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.53 1.48 1.58 1.48 1.53
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15/4/202407:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
09/4/202411:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05/4/202407:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
11/3/202415:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202415:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
05/3/202416:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202415:46EDGAR2Form 8-K - Current report
05/3/202415:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
26/2/202415:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
08/1/202407:11EDGAR2Form 8-K - Current report
21/12/202307:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
24/11/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:12GLOBEIO Biotech Announces 2023 Third Quarter Results
13/11/202307:10EDGAR2Form 8-K - Current report
13/11/202307:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
10/11/202307:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
08/11/202315:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
01/11/202307:30GLOBEIO Biotech Presents Three Posters at the Society for..
23/10/202300:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
03/10/202315:30GLOBEIO Biotech Announces Three Poster Presentations at the..
12/9/202315:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/9/202307:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
10/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
07/9/202309:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202307:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
30/8/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
15/8/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202316:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/8/202320:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202307:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202307:31EDGAR2Form 8-K - Current report
11/8/202307:30GLOBEIO Biotech Announces 2023 Second Quarter Results
11/8/202307:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
09/8/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202307:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
07/8/202307:31EDGAR2Form 8-K - Current report
07/8/202307:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
28/7/202307:05GLOBEIO Biotech Announces First Patient Dosed in..
25/7/202315:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
19/7/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202315:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/7/202315:05EDGAR2Form 8-K - Current report
18/7/202315:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
14/6/202307:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
01/6/202307:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

Su Consulta Reciente

NASDAQ
IOBT
IO Biotech
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados